secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENXBIO Inc. (RGNX)
CIK:        0001590877
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0000950170-23-026437
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

REGENXBIO shareholders elect all three Class II director nominees at annual meeting
--------------------------------------------------------------------------------

- Jean Bennett, Jerry Karabelas, and Daniel Tassé elected as Class II directors with 30.3M, 35.5M, and 36.0M votes for, respectively.
- Ratification of PricewaterhouseCoopers as independent auditor for FY2023 approved: 39.8M for, 50.7K against.
- Advisory (non-binding) vote on named executive officer compensation passed with 36.7M for, 1.1M against.
- Broker non-votes were 1,965,878 for director election and say-on-pay; none for auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/0000950170-23-026437-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590877/000095017023026437/rgnx-20230602.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-026437

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer